<?xml version="1.0"?>
<ref-list>
	<ref id="R1">
		<label>1</label>
		<nlm-citation citation-type="journal">
			<person-group person-group-type="author">
				<name>
					<surname>Oosterlinck</surname>
					<given-names>O</given-names>
				</name>
				<name>
					<surname>van der Meijden</surname>
					<given-names>A</given-names>
				</name>
			</person-group>
			<source>Guidelines on TaT1 (Non-muscle invasive) Bladder Cancer. European Association of Urology Guidelines</source>
			<year>2007</year>
			<fpage>1</fpage>
			<lpage>17</lpage>
		</nlm-citation>
	</ref>
	<ref id="R2">
		<label>2</label>
		<nlm-citation citation-type="journal">
			<person-group person-group-type="author">
				<name>
					<surname>Loidl</surname>
					<given-names>W</given-names>
				</name>
				<name>
					<surname>Schmidbauer</surname>
					<given-names>J</given-names>
				</name>
				<name>
					<surname>Susani</surname>
					<given-names>M</given-names>
				</name>
			</person-group>
			<article-title>Flexible Cystoscopy assisted by Hexaminolevulinate Induced Fluorescence: A New Approach for Bladder Cancer Detection
and Surveillance?</article-title>
			<source>Eur Urol</source>
			<year>2005</year>
			<volume>47</volume>
			<fpage>323</fpage>
			<lpage>326</lpage>
		</nlm-citation>
	</ref>
</ref-list>